Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

9.26
-0.1300-1.38%
Volume:1.61M
Turnover:15.03M
Market Cap:817.93M
PE:-2.91
High:9.60
Open:9.48
Low:9.20
Close:9.39
52wk High:12.49
52wk Low:5.41
Shares:88.33M
Float Shares:63.99M
Volume Ratio:0.74
T/O Rate:2.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1784
EPS(LYR):-3.1784
ROE:-94.82%
ROA:-25.33%
PB:4.70
PE(LYR):-2.91

Loading ...

Kura Oncology management to meet with Citizens

TIPRANKS
·
Mar 04

Kura Oncology Inc expected to post a loss of 61 cents a share - Earnings Preview

Reuters
·
Mar 03

Kura Oncology Inc. to Report Fourth-Quarter and Full-Year Financial Results, Host Conference Call and Webcast

Reuters
·
Feb 26

Kura Oncology to Participate in TD Cowen, Leerink Partners, and Barclays Investor Conferences

Reuters
·
Feb 25

Kura Oncology (KURA) Gets a Buy from Wedbush

TIPRANKS
·
Feb 16

Kura Oncology reports inducement grants under Nasdaq listing rule

TIPRANKS
·
Feb 06

Kura Oncology Grants Stock Options to New Employees Under Inducement Plan

Reuters
·
Feb 06

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Feb 06

Barclays Remains a Buy on Kura Oncology (KURA)

TIPRANKS
·
Feb 04

Kura Oncology Tightens Governance with Amended Bylaws

TIPRANKS
·
Jan 30

Kura Oncology SVP Thomas James Doyle Disposes of Common Shares

Reuters
·
Jan 28

Kura Oncology Chief Medical Officer Mollie Leoni Reports Sale of Common Shares

Reuters
·
Jan 28

Analysts’ Top Healthcare Picks: Kura Oncology (KURA), UnitedHealth (UNH)

TIPRANKS
·
Jan 28

Kura Oncology price target lowered to $20 from $25 at Leerink

TIPRANKS
·
Jan 13

Kura Oncology Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
Jan 13

Kura Oncology Inc : Leerink Partners Cuts Target Price to $20 From $25

THOMSON REUTERS
·
Jan 13

Barclays Sticks to Its Buy Rating for Kura Oncology (KURA)

TIPRANKS
·
Jan 13

Kura Oncology Unveils Precision Medicine Advances and Pipeline Expansion in New Corporate Presentation

Reuters
·
Jan 13

Analysts Offer Insights on Healthcare Companies: Cerus (CERS) and Kura Oncology (KURA)

TIPRANKS
·
Jan 12

Kura Oncology projects $45M–$55M in non-cash collaboration revenue for 2026

Reuters
·
Jan 12